Bui, D.; McWilliams, L.A.; Wu, L.; Zhou, H.; Wong, S.J.; You, M.; Chow, D.S.-L.; Singh, R.; Hu, M.
Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans. Cancers 2023, 15, 89.
https://doi.org/10.3390/cancers15010089
AMA Style
Bui D, McWilliams LA, Wu L, Zhou H, Wong SJ, You M, Chow DS-L, Singh R, Hu M.
Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans. Cancers. 2023; 15(1):89.
https://doi.org/10.3390/cancers15010089
Chicago/Turabian Style
Bui, Dinh, Lenora A. McWilliams, Lei Wu, Haiying Zhou, Stuart J. Wong, Ming You, Diana S.-L. Chow, Rashim Singh, and Ming Hu.
2023. "Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans" Cancers 15, no. 1: 89.
https://doi.org/10.3390/cancers15010089
APA Style
Bui, D., McWilliams, L. A., Wu, L., Zhou, H., Wong, S. J., You, M., Chow, D. S. -L., Singh, R., & Hu, M.
(2023). Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans. Cancers, 15(1), 89.
https://doi.org/10.3390/cancers15010089